Dysregulation of growth signaling pathways can lead to various diseases, including cancer. Overexpression or mutation of growth factors and their receptors can result in uncontrolled cell proliferation. For example, mutations in the HER2/neu receptor are associated with certain types of breast cancer. Additionally, defects in downstream signaling components like Ras or PI3K can also contribute to oncogenesis.
